Quadcap Wealth Management »

Ovid Therapeutics shares owned by Quadcap Wealth Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Quadcap Wealth Management from 13F filings

Historical chart of Quadcap Wealth Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Quadcap Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Quadcap Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 15k 1.30

More positions owned by Quadcap Wealth Management

J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Dimensional Etf Trust Us Equity Market (DFUS)
Apple (AAPL)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Morgan Stanley Etf Trust Eaton Vance Tota (EVTR)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Dimensional Etf Trust Intl High Profit (DIHP)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard World Mega Grwth Ind (MGK)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)

View all positions for Quadcap Wealth Management

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Vanguard Group
Affinity Asset Advisors
Acadian Asset Management
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Kennedy Capital Management
Ikarian Capital
Millennium Management
Assenagon Asset Management
Schonfeld Strategic Advisors
Marshall Wace
Wells Fargo & Company

View all funds holding Ovid Therapeutics